Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
November 2012 Volume 28 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November 2012 Volume 28 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Increased Pontin expression is a potential predictor for outcome in sporadic colorectal carcinoma

  • Authors:
    • Johannes C. Lauscher
    • Sefer Elezkurtaj
    • Sonja Dullat
    • Sybille Lipka
    • Jörn Gröne
    • Heinz J. Buhr
    • Otmar Huber
    • Martin Kruschewski
  • View Affiliations / Copyright

    Affiliations: Department of General, Vascular and Thoracic Surgery, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, D-12200 Berlin, Germany, Department of Pathology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, D-12200 Berlin, Germany, Department of Ophthalmology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, D-12200 Berlin, Germany, Institute of Biochemistry II, Jena University Hospital, Friedrich-Schiller-University Jena, Nonnenplan 2, D-07743 Jena, Germany
  • Pages: 1619-1624
    |
    Published online on: August 10, 2012
       https://doi.org/10.3892/or.2012.1968
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Colorectal cancer is one of the leading causes of cancer-related death worldwide. Molecular biomarkers could help to predict patient outcome and to identify patients who benefit from adjuvant therapy. Pontin and Reptin are ATPases which are involved in transcriptional regulation, DNA damage repair and regulation of cell proliferation. Many interaction partners of Pontin and Reptin such as β-catenin and c-myc are important factors in carcinogenesis. We hypothesized that Pontin and Reptin expression may be a negative predictor for survival in colorectal carcinoma. Specimens from 115 patients with primary colon adenocarcinomas UICC stage III and primary rectal adenocarcinomas UICC stage II and III curatively resected at the Department of Surgery, Charité Berlin, were evaluated. Clinical follow-up data were complete and mean follow-up time of patients was 51.8 months. We evaluated the expression of Pontin, Reptin and Ki-67 by immunohistochemistry. Patients with Pontin-positive carcinomas showed no differences in recurrence-free survival (p=0.109) and overall survival (p=0.197). There were no differences in Reptin-positive carcinomas and Ki-67-positive carcinomas in recurrence-free survival (p=0.443 and p=0.160) and overall survival (p=0.477 and p=0.687). Patients with Pontin-positive colorectal carcinomas receiving adjuvant therapy had a significantly worse recurrence-free survival (p=0.008) and overall survival (p=0.011) than Pontin-negative patients with adjuvant therapy. In UICC stage III, Pontin-positive colorectal carcinomas had a significantly worse recurrence-free survival (p=0.028). Pontin-positivity seems to be a negative predictor for response to adjuvant therapy in colorectal cancer patients and may help to identify patients with adverse outcome in advanced tumor stages.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin. 57:43–66. 2007. View Article : Google Scholar

2 

Nehls O, Okech T, Hsieh CJ, Enzinger T, Sarbia M, Borchard F, Gruenagel HH, Gaco V, Hass HG, Arkenau HT, et al: Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX. Br J Cancer. 96:1409–1418. 2007.

3 

Mamounas E, Wieand S, Wolmark N, Bear HD, Atkins JN, Song J and Rockette H: Comparative efficacy of adjuvant chemotherapy in patients with Dukes’ B versus Dukes’ C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03 and C-04). J Clin Oncol. 17:1349–1355. 1999.

4 

Aneja R, Ghaleh AM, Zhou J, Yang VW and Joshi HC: p53 and p21 determine the sensitivity of noscapine-induced apoptosis in colon cancer cells. Cancer Res. 67:3862–3870. 2007. View Article : Google Scholar : PubMed/NCBI

5 

Bauer A, Huber O and Kemler R: Pontin52, an interaction partner of β-catenin, binds to the TATA box binding protein. Proc Natl Acad Sci USA. 95:14787–14792. 1998.

6 

Bauer A, Chauvet S, Huber O, Usseglio F, Rothbächer U, Aragnol D, Kemler R and Pradel J: Pontin52 and reptin52 as antagonistic regulators of beta-catenin signalling activity. EMBO J. 19:6121–6130. 2000. View Article : Google Scholar : PubMed/NCBI

7 

Grigoletto A, Lestienne P and Rosenbaum J: The multifaceted proteins Reptin and Pontin as major players in cancer. Biochim Biophys Acta. 1815:147–157. 2011.PubMed/NCBI

8 

Huber O, Ménard L, Haurie V, Nicou A, Taras D and Rosenbaum J: Pontin and reptin, two related ATPases with multiple roles in cancer. Cancer Res. 68:6873–6876. 2008. View Article : Google Scholar : PubMed/NCBI

9 

Polakis P: The oncogenic activation of beta-catenin. Curr Opin Gen Dev. 9:15–21. 1999. View Article : Google Scholar

10 

Rottbauer W, Saurin AJ, Lickert H, Shen X, Burns CG, Wo ZG, Kemler R, Kingston R, Wu C and Fishman M: Reptin and pontin antagonistically regulate heart growth in zebrafish embryos. Cell. 111:661–672. 2002. View Article : Google Scholar : PubMed/NCBI

11 

Weiske J and Huber O: The histidine triad protein Hint1 interacts with Pontin and Reptin and inhibits TCF-beta-catenin-mediated transcription. J Cell Sci. 118:3117–3129. 2005. View Article : Google Scholar : PubMed/NCBI

12 

Rashid S, Pilecka I, Torun A, Olchowik M, Bielinska B and Miaczynska M: Endosomal adaptor proteins APPL1 and APPL2 are novel activators of beta-catenin/TCF-mediated transcription. J Biol Chem. 284:18115–18128. 2009. View Article : Google Scholar : PubMed/NCBI

13 

Kim JH, Kim B, Cai L, Choi HJ, Ohgi KA, Tran C, Chen C, Chung CH, Huber O, Rose DW, et al: Transcriptional regulation of a metastasis suppressor gene by Tip60 and beta-catenin complexes. Nature. 434:921–926. 2005. View Article : Google Scholar : PubMed/NCBI

14 

Etard C, Gradl D, Kunz M, Eilers M and Wedlich D: Pontin and Reptin regulate cell proliferation in early Xenopus embryos in collaboration with c-Myc and Miz-1. Mech Dev. 122:545–556. 2005. View Article : Google Scholar : PubMed/NCBI

15 

Li W, Zeng J, Li Q, Zhao L, Liu T, Bjorkholm M, Jia J and Xu D: Reptin is required for the transcription of telomerase reverse transcriptase and over-expressed in gastric cancer. Mol Cancer. 9:1322010. View Article : Google Scholar : PubMed/NCBI

16 

Bellosta P, Hulf T, Balla Diop S, Usseglio F, Pradel J, Aragnol D and Gallant P: Myc interacts genetically with Tip48/Reptin and Tip49/Pontin to control growth and proliferation during Drosophila development. Proc Natl Acad Sci USA. 102:11799–11804. 2005. View Article : Google Scholar : PubMed/NCBI

17 

Si J, Yu X, Zhang Y and DeWille JW: Myc interacts with Max and Miz1 to repress C/EBPdelta promoter activity and gene expression. Mol Cancer. 9:922010. View Article : Google Scholar : PubMed/NCBI

18 

Sun Y, Jiang X and Price BD: Tip60: connecting chromatin to DNA damage signaling. Cell Cycle. 9:930–936. 2010. View Article : Google Scholar : PubMed/NCBI

19 

Tyteca S, Vandromme M, Legube G, Chevillard-Briet M and Trouche D: Tip60 and p400 are both required for UV-induced apoptosis but play antagonistic roles in cell cycle progression. EMBO J. 25:1680–1689. 2006. View Article : Google Scholar : PubMed/NCBI

20 

Jha S, Shibata E and Dutta A: Human Rvb1/Tip49 is required for the histone acetyltransferase activity of Tip60/NuA4 and for the down-regulation of phosphorylation on H2AX after DNA damage. Mol Cell Biol. 28:2690–2700. 2008. View Article : Google Scholar : PubMed/NCBI

21 

Dugan KA, Wood MA and Cole MD: TIP49, but not TRRAP, modulates c-Myc and E2F1 dependent apoptosis. Oncogene. 21:5835–5843. 2002. View Article : Google Scholar : PubMed/NCBI

22 

Haurie V, Menard L, Nicou A, Touriol C, Metzler P, Fernandez J, Taras D, Lestienne P, Balabaud C, Bioulac-Sage P, et al: Adenosine triphosphatase pontin is overexpressed in hepatocellular carcinoma and coregulated with reptin through a new posttranslational mechanism. Hepatology. 50:1871–1883. 2009. View Article : Google Scholar

23 

Bullwinkel J, Baron-Lühr B, Lüdemann A, Wohlenberg C, Gerdes J and Scholzen T: Ki-67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells. J Cell Physiol. 206:624–635. 2006. View Article : Google Scholar : PubMed/NCBI

24 

Scholzen T and Gerdes J: The Ki-67 protein: from the known and the unknown. J Cell Physiol. 182:311–322. 2000. View Article : Google Scholar : PubMed/NCBI

25 

Funaioli C, Pinto C, Mutri V, Di Fabio F, Ceccarelli C and Martoni AA: Does biomolecular characterization of stage II/III colorectal cancer have any prognostic value? Clin Colorectal Cancer. 6:38–45. 2006. View Article : Google Scholar : PubMed/NCBI

26 

Kuremsky JG, Tepper JE and McLeod HL: Biomarkers for response to neoadjuvant chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys. 74:673–688. 2009. View Article : Google Scholar : PubMed/NCBI

27 

Lauscher JC, Loddenkemper C, Kosel L, Gröne J, Buhr HJ and Huber O: Increased pontin expression in human colorectal cancer tissue. Hum Pathol. 38:978–985. 2007. View Article : Google Scholar : PubMed/NCBI

28 

Wood MA, McMahon SB and Cole MD: An ATPase/helicase complex is an essential cofactor for oncogenic transformation by c-Myc. Mol Cell. 5:321–330. 2000. View Article : Google Scholar : PubMed/NCBI

29 

Feng Y, Lee N and Fearon ER: TIP49 regulates β-catenin-mediated neoplastic transformation and T-cell factor target gene induction via effects on chromatin remodeling. Cancer Res. 63:8726–8734. 2003.

30 

Ki DH, Jeung HC, Park CH, Kang SH, Lee GY, Lee WS, Kim NK, Chung HC and Rha SY: Whole genome analysis for liver metastasis gene signatures in colorectal cancer. Int J Cancer. 121:2005–2012. 2007. View Article : Google Scholar : PubMed/NCBI

31 

Li W, Zeng J, Li Q, Zhao L, Liu T, Bjorkholm M, Jia J and Xu D: Reptin is required for the transcription of telomerase reverse transcriptase and over-expressed in gastric cancer. Mol Cancer. 9:1322010. View Article : Google Scholar : PubMed/NCBI

32 

Sanchez-Carbayo M, Socci ND, Lozano J, Saint F and Cordon-Cardo C: Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J Clin Oncol. 24:778–789. 2006. View Article : Google Scholar

33 

Dehan E, Ben-Dor A, Liao W, Lipson D, Frimer H, Rienstein S, Simansky D, Krupsky M, Yaron P, Friedman E, et al: Chromosomal aberrations and gene expression profiles in non-small cell lung cancer. Lung Cancer. 56:175–184. 2007. View Article : Google Scholar : PubMed/NCBI

34 

Rousseau B, Menard L, Haurie V, Taras D, Blanc J, Moreau-Gaudry F, Metzler P, Hugues M, Boyault S, Lemiere S, et al: Overexpression and role of the ATPase and putative DNA helicase RuvB-like 2 in human hepatocellular carcinoma. Hepatology. 46:1108–1118. 2007. View Article : Google Scholar : PubMed/NCBI

35 

Notaridou M, Quaye L, Dafou D, Jones C, Song H, Hogdall E, Kjaer SK, Christensen L, Hogdall C, Blaakaer J, et al: Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer. Int J Cancer. 128:2063–2074. 2011. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Lauscher JC, Elezkurtaj S, Dullat S, Lipka S, Gröne J, Buhr HJ, Huber O and Kruschewski M: Increased Pontin expression is a potential predictor for outcome in sporadic colorectal carcinoma. Oncol Rep 28: 1619-1624, 2012.
APA
Lauscher, J.C., Elezkurtaj, S., Dullat, S., Lipka, S., Gröne, J., Buhr, H.J. ... Kruschewski, M. (2012). Increased Pontin expression is a potential predictor for outcome in sporadic colorectal carcinoma. Oncology Reports, 28, 1619-1624. https://doi.org/10.3892/or.2012.1968
MLA
Lauscher, J. C., Elezkurtaj, S., Dullat, S., Lipka, S., Gröne, J., Buhr, H. J., Huber, O., Kruschewski, M."Increased Pontin expression is a potential predictor for outcome in sporadic colorectal carcinoma". Oncology Reports 28.5 (2012): 1619-1624.
Chicago
Lauscher, J. C., Elezkurtaj, S., Dullat, S., Lipka, S., Gröne, J., Buhr, H. J., Huber, O., Kruschewski, M."Increased Pontin expression is a potential predictor for outcome in sporadic colorectal carcinoma". Oncology Reports 28, no. 5 (2012): 1619-1624. https://doi.org/10.3892/or.2012.1968
Copy and paste a formatted citation
x
Spandidos Publications style
Lauscher JC, Elezkurtaj S, Dullat S, Lipka S, Gröne J, Buhr HJ, Huber O and Kruschewski M: Increased Pontin expression is a potential predictor for outcome in sporadic colorectal carcinoma. Oncol Rep 28: 1619-1624, 2012.
APA
Lauscher, J.C., Elezkurtaj, S., Dullat, S., Lipka, S., Gröne, J., Buhr, H.J. ... Kruschewski, M. (2012). Increased Pontin expression is a potential predictor for outcome in sporadic colorectal carcinoma. Oncology Reports, 28, 1619-1624. https://doi.org/10.3892/or.2012.1968
MLA
Lauscher, J. C., Elezkurtaj, S., Dullat, S., Lipka, S., Gröne, J., Buhr, H. J., Huber, O., Kruschewski, M."Increased Pontin expression is a potential predictor for outcome in sporadic colorectal carcinoma". Oncology Reports 28.5 (2012): 1619-1624.
Chicago
Lauscher, J. C., Elezkurtaj, S., Dullat, S., Lipka, S., Gröne, J., Buhr, H. J., Huber, O., Kruschewski, M."Increased Pontin expression is a potential predictor for outcome in sporadic colorectal carcinoma". Oncology Reports 28, no. 5 (2012): 1619-1624. https://doi.org/10.3892/or.2012.1968
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team